Cargando…
Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the foref...
Autores principales: | Arnst, Nikita, Redolfi, Nelly, Lia, Annamaria, Bedetta, Martina, Greotti, Elisa, Pizzo, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775979/ https://www.ncbi.nlm.nih.gov/pubmed/36551781 http://dx.doi.org/10.3390/biomedicines10123025 |
Ejemplares similares
-
Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
por: Galla, Luisa, et al.
Publicado: (2020) -
A New Transgenic Mouse Line for Imaging Mitochondrial Calcium Signals
por: Redolfi, Nelly, et al.
Publicado: (2021) -
Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer’s Disease
por: Rossi, Alice, et al.
Publicado: (2021) -
Mitochondrial bioenergetics and neurodegeneration: a paso doble
por: Rossi, Alice, et al.
Publicado: (2020) -
Characterization of the ER-Targeted Low Affinity Ca(2+) Probe D4ER
por: Greotti, Elisa, et al.
Publicado: (2016)